Contract facts
NONENo full NAICS 621991 intel page yet. Browse NAICS intelligence
BLOOD PRODUCTS is a federal NONE award for Defense Health Agency held by American National Red Cross, the. Estimated value $2.1M ($2.1M obligated). Current period of performance ends Apr 6, 2027. Last award drew 1 bidder. Place of performance: BETHESDA MD.
Recompete timing
PublicCurrent PoP ends Apr 6, 2027 (228 days remaining). Agencies typically plan 12–18 months ahead — at 7.5 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordAmerican National Red Cross, the — $80.4M obligated across 322 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001426FE045?
HT001426FE045 (BLOOD products) is a Defense Health Agency award with a potential value of $2.1M, currently held by American National Red Cross, the. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT001426FE045?
Defense Health Agency awarded HT001426FE045 to American National Red Cross, the (potential $2.1M).
Who is the incumbent on HT001426FE045?
American National Red Cross, the is the incumbent with $80.4M across 322 related awards in SCOUT’s public footprint. The current period of performance ends Apr 6, 2027.
When does American National Red Cross, the’s HT001426FE045 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 6, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
